Predicting Outcome of Total Knee Replacement Surgery in Patients With Knee Osteoarthritis
Launched by UNIVERSITEIT ANTWERPEN · May 13, 2022
Trial Information
Current as of July 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Knee OA patients \>40 years awaiting TKR surgery. Both men and women of all ethnical backgrounds are included.
- Exclusion Criteria:
- • Patients with diagnosis of neurological/ systemic diseases, possibly impacting pain
- • Patients who are not capable of understanding and speaking Dutch
- • Revision surgery
About Universiteit Antwerpen
The University of Antwerp is a leading research institution based in Belgium, renowned for its commitment to advancing knowledge and innovation in various scientific fields. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to improve healthcare outcomes and enhance understanding of complex medical conditions. The University of Antwerp's dedicated research teams leverage cutting-edge methodologies and state-of-the-art facilities to conduct rigorous studies, ensuring adherence to the highest ethical standards and regulatory requirements. Through its clinical trial initiatives, the university strives to translate research findings into practical applications that benefit patients and contribute to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antwerp, , Belgium
Patients applied
Trial Officials
Sophie Vervullens
Principal Investigator
Universiteit Antwerpen
Lotte Meert
Principal Investigator
Universiteit Antwerpen
Mira Meeus
Principal Investigator
Universiteit Antwerpen
Isabel Baert
Principal Investigator
Universiteit Antwerpen
Rob J.E.M. Smeets
Principal Investigator
Maastricht University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials